menu Home

Program

  • DAY 1 / September 2(Fri)
  • DAY 2 / September 3(Sat)

DAY 1 / September 2(Fri). 2022

SC Convention Anais Hall (12F), Seoul, Korea
Time Program Chair / Speaker
10:50-12:00 Poster Session
12:00-13:00 Lunch
13:00-13:20 Opening Ceremony Seong Il SEO (President, KPS)
Ji Youl LEE (President, APSU)
Sang Don LEE (President, KUA)
13:20-14:25 Session I: Prostate Cancer I Sung Kyu HONG (Korea)
Bannakij LOJANAPIWAT (Thailand)
13:20-13:50 Radioguided Surgery: a Novel Application of PSMA PET Imaging Robert REITER (USA)
13:50-14:00 Metastasis-Directed Treatment for Oligometastatic Disease Wansuk KIM (Korea)
14:00-14:15 Efficacy of a Focal Boost to the Intraprostatic Tumor in EBRT for Localized Prostate Cancer Sung Uk Lee (Korea)
14:15-14:25 Panel Discussion Jae Young PARK (Korea)
Jun Hyun HAN (Korea)
In Chang CHO (Korea)
14:25-15:25 Session II: Urothelial Cancer I Ji Youl LEE (Korea)
Teng Aik ONG (Malaysia)
14:25-14:55 Innovations and Novel Therapies for BCG Unresponsive NMIBC Seth LERNER (USA)
14:55-15:05 Partial BCG Instillation for High-Risk NMIBC: Would It be an Exit for a BCG Shortage? Hyeong Dong YUK (Korea)
15:05-15:15 Urinary Biomarkers in Bladder Cancer Surveillance See Min CHOI (Korea)
15:15-15:25 Panel Discussion Jun Sung KOH (Korea)
Jeong Seok HWA (Korea)
In Ho CHANG (Korea)
15:25-15:40 Coffee Break
15:40-16:40 Session III: Kidney Cancer I Kyung Seop LEE (Korea)
Lukman HAKIM (Indonesia)
15:40-16:10 The Contemporary Role of Cytoreductive Surgery in Kidney Cancer Brian M. SHUCH (USA)
16:10-16:20 Emerging Biomarkers to Identify Patients with High-Risk Non-Metastatic RCC Chan Ho LEE (Korea)
16:20-16:30 The Role of Adjuvant Therapy After Radical Nephrectomy for High-Risk RCC Jeong Woo LEE (Korea)
16:30-16:40 Panel Discussion Taek Won KANG (Korea)
Seok Joong YUN (Korea)
Jae Seung CHUNG (Korea)
Edmund CHIONG (Singapore)
16:40-17:10 Satellite Symposium Sponsored by Janssen
16:40-17:10 Role of Abiraterone in Metastatic Prostate Cancer: Looking Back on 10 Years Taek Won KANG (Korea)
17:10 Welcome Dinner

DAY 2 / September 3(Sat). 2022

SC Convention International Conference Hall (B1F), Seoul, Korea
Time Program Chair / Speaker
09:00-10:15 Session IV: Kidney Cancer II Seong Il SEO (Korea)
Edmund CHIONG (Singapore)
09:00-09:30 Germline Genetic Risk Assessment for Kidney Cancer: Who/What/Where/When/and How Brian M. SHUCH (USA)
09:30-09:40 Evolving Landscape of the Systemic Treatment for Metastatic Clear Cell RCC in the Era of Immunotherapy Hyun Ho HAN (Korea)
09:40-09:50 Role of Metastasectomy for Metastatic RCC: Update Joongwon CHOI (Korea)
09:50-10:00 Treatment of Metastatic Non-Clear Cell RCC: Where Are We? Jung Jun KIM (Korea)
10:00-10:15 Panel Discussion Seung Hwan LEE (Korea)
Tae Hyo KIM (Korea)
Lukman HAKIM (Indonesia)
10:15-10:30 Coffee Break
10:30-11:15 Session V: Prostate Cancer II Seung-Ju LEE (Korea)
Seung Hyun JEON (Korea)
10:30-10:40 Salvage Robotic-Assisted Radical Prostatectomy After Focal or Whole Gland Therapy: Is It Feasible? Hakmin LEE (Korea)
10:40-10:50 BCR in 2022: What Test Can Be Done on Patients with Suspected BCR in the Era of Multi-Parametric MRI and PET-CT? Jae Duck CHOI (Korea)
10:50-11:00 Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy for Patients With Locally Advanced Prostate Cancer Won Tae KIM (Korea)
11:00-11:15 Panel Discussion Chang Wook JEONG (Korea)
Hwang Gyun JEON (Korea)
U-Syn HA (Korea)
Bannakij LOJANAPIWAT (Thailand)
11:15-11:30 KPS BLUE Award
11:15-11:25 KPS BLUE Award
11:25-11:30 Commemorative Photo
11:30-12:00 Luncheon Symposium - Sponsored by Astellas
11:30-12:00 The First Reimbursed Option for mHSPC All-comers, Enzalutamide Hyun Ho HAN (Korea)
12:00-13:00 Lunch
13:00-14:15 Session VI: Prostate Cancer III Hyun Moo LEE (Korea)
Byung Ha CHUNG (Korea)
13:00-13:30 Update from the Advanced Prostate Cancer Consortium: Controversies and Consensus Robert REITER (USA)
13:30-13:40 Bipolar Androgen Therapy for Asymptomatic mCRPC: Myth or Reality? Won Ik SEO (Korea)
13:40-13:50 Prevention of the Skeletal-Related Event with a Bone Protecting Agent for Patients with Bone Metastatic CRPC Se Young CHOI (Korea)
13:50-14:00 PSMA Beyond Imaging Byung Hoon KIM (Korea)
14:00-14:15 Panel Discussion Jae Young JOUNG (Korea)
Chang Hee YOO (Korea)
Jin Kyu OH (Korea)
14:15-14:30 Coffee Break
14:30-15:35 Session VII: Urothelial Cancer II Choung Soo KIM (Korea)
Tag Keun YOO (Korea)
14:30-15:00 Contemporary Management of MIBC: Systemic Therapy, Radical Cystectomy, and Bladder Sparing Seth LERNER (USA)
15:00-15:15 The Role of Multi-Parametric MRI and VI-RADS for Local Staging of Muscle Invasive Bladder Cancer Kye Jin PARK (Korea)
15:15-15:25 Management of Distal Ureter during Nephroureterectomy for Upper Tract Urothelial Carcinoma Wan SONG (Korea)
15:25-15:35 Panel Discussion Phil Hyun SONG (Korea)
Yun Beom KIM (Korea)
Teng Aik ONG (Malaysia)
15:35-16:20 Session VIII: Potpourri Jun Hyuk HONG (Korea)
Moon Ki JO (Korea)
15:35-15:45 Recent Updates in Treatment for Metastatic Testicular Germ Cell Tumor Yun-Sok HA (Korea)
15:45-15:55 Neoadjuvant Chemotherapy for Patients with Lymph Node-Positive Penile Cancer Hongzoo PARK (Korea)
15:55-16:05 Do Newer Minimally Invasive Surgical Interventions for BPH Affect Sexual Function of Patients? Seo Yeon LEE (Korea)
16:05-16:20 Panel Discussion Jihyeong YU (Korea)
Sung Dae KIM (Korea)
Jae Hyun RYU (Korea)
16:20-16:30 Closing Remark
go to top

Copyright(C) by 2022 KPS-APSU Joint International Symposium.
All rights reserved.

Secretariat of 2022 KPS-APSU

Gaon Convention Services, Inc.
ADDRESS: ROOM 301, 347, HWAGOK-RO, GANGSEO-GU, SEOUL, REPUBLIC OF KOREA.
TEL : +82-2-6956-7989   |   E-MAIL : gaonpco@gaonpco.com

close

사전등록

등록구분
근무처
소속의사회

* 의사 회원인 경우에는 연수평점 카드 기록을 위해서 필요 합니다.